Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
148.6 USD | -0.46% | +1.20% | -5.21% |
05-06 | J&J: encouraging results in prostate cancer | CF |
05-06 | J&J: positive results in bladder cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.21% | 358B | |
+31.52% | 690B | |
+24.62% | 546B | |
+17.02% | 323B | |
+5.01% | 287B | |
+14.00% | 235B | |
+5.20% | 199B | |
-9.94% | 195B | |
+3.98% | 161B | |
-2.19% | 159B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson : Morgan Stanley Adjusts Price Target for Johnson & Johnson to $178 From 4179, Maintains Overweight Rating